T1	HMM 28 43	cervical cancer
T2	HMM 222 258	effectiveness and cost-effectiveness
T3	HMM 1149 1170	frequency of testing.
T4	HMM 1175 1194	total response rate
T5	HMM 1550 1569	no additional cost.
T6	HMM 1641 1654	participation
T7	HMM 1763 1776	participation
